small-cap

How NVOX Works: The Mechanics of the Defiance Daily Target 2X Long NVO ETF

Oct 15, 2026 | Team Kalkine

Read Time :10 Mins

How NVOX Works: The Mechanics of the Defiance Daily Target 2X Long NVO ETF — Image source: shutterstock

The Defiance Daily Target 2X Long NVO ETF (NYSE Arca: NVOX) seeks to deliver two times (+200%) the daily percentage change in the share price of Novo Nordisk A/S’s American Depositary Receipt (NYSE: NVO), before fees and expenses. The fund launched on December 2, 2024. It gives traders amplified bullish exposure to Novo Nordisk without requiring them to buy the ADR or use margin. Its leverage resets every day, so it is a short-term tactical instrument rather than a long-term holding.

Novo Nordisk is a Danish pharmaceutical company best known for diabetes care and obesity treatments. It also has businesses in hemophilia, growth disorders and hormone therapy. Its share price can react to clinical trial results, regulatory decisions, weight-loss drug demand, pricing pressure, competition, earnings and guidance, and broader healthcare-sector sentiment.

NVOX amplifies NVO’s daily moves. If NVO rises 3% in a session, NVOX aims to gain about 6%. If NVO falls 3%, NVOX aims to lose about 6%. Both figures are before fees, expenses and tracking differences. The fund pursues this objective mainly through swap agreements on NVO and does not invest directly in the stock.

This report is available to subscribers only

Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Mid-Cap